Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Focal Seizures, Partial Seizures”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableWithdrawnNCT05738226
What this trial is testing

EpiCare@Home Validation Study for Focal Onset Seizures

Who this might be right for
EpilepsySeizuresSeizures, Focal+1 more
Byteflies
Large-scale testing (Phase 3)Study completedNCT01392768
What this trial is testing

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Who this might be right for
EpilepsyPartial Seizures
Ache Laboratorios Farmaceuticos S.A. 126
Not applicableActive Not RecruitingNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Large-scale testing (Phase 3)Study completedNCT00230698
What this trial is testing

The Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451
Not applicableStudy completedNCT00001666
What this trial is testing

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

Who this might be right for
Partial EpilepsySeizures
National Institute of Neurological Disorders and Stroke (NINDS) 32
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03283371
What this trial is testing

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Who this might be right for
Epilepsy, Focal Seizures, Partial Seizures
Biogen 67
Not applicableLooking for participantsNCT06466681
What this trial is testing

Changes in Attentional Control After a Focal Seizure.

Who this might be right for
Temporal Lobe EpilepsyFrontal Lobe EpilepsyOthers Subtypes
University Hospital, Lille 100
Large-scale testing (Phase 3)Study completedNCT01262677
What this trial is testing

Once-A-Day Pregabalin For Partial Seizures

Who this might be right for
Partial SeizuresEpilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Study completedNCT00236743
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90
Large-scale testing (Phase 3)Study completedNCT00355082
What this trial is testing

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 226
Not applicableLooking for participantsNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 190
Not applicableUnknownNCT03457961
What this trial is testing

Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong

Who this might be right for
Focal EpilepsyGeneralized EpilepsyPartial Seizures, Simple
Chinese University of Hong Kong 80
Testing effectiveness (Phase 2)WithdrawnNCT00982787
What this trial is testing

Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy

Who this might be right for
Partial Epilepsy
Oregon Health and Science University
Testing effectiveness (Phase 2)Looking for participantsNCT07219407
What this trial is testing

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Who this might be right for
Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00552305
What this trial is testing

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Who this might be right for
Partial Epilepsies
UCB Pharma 370
Testing effectiveness (Phase 2)Looking for participantsNCT07141329
What this trial is testing

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset Seizures
Supernus Pharmaceuticals, Inc. 100
Load More Results